Global and UK epidemiology of Gram-negative infections

Dr Susan Hopkins, Healthcare-Associated Infection & Antimicrobial Resistance Division, Deputy Director, National Infection Service, Public Health England

Understanding resistance mechanisms and their applications into practice

Professor Peter Hawkey, Professor of Clinical and Public Health Bacteriology, University of Birmingham

Drug R&D to combat Gram-negative infections

Dr David Roblin, CEO Summit Therapeutics

Clinical presentations and impact of Gram-negative infections

Dr Gavin Barlow Consultant in Infection, Hull & East Yorkshire Hospitals NHS Trust and Hon. Senior Clinical Lecturer, Hull York Medical School

PK-PD challenges for Gram-negative infections

Professor William Hope, Professor of Therapeutics and Infectious Diseases, University of Liverpool

Advances in betalactamase inhibition in difficult to treat infections

Dr Shampa Das, Senior Lecturer, University of Liverpool

Invited paper: Compassionate use of Cefiderocol for Multi-drug resistant Acinetobacter baumannii orthopaedic infection following surgery in Pakistan

Dr Diana A Mabayoje, Microbiology SpR, Homerton Hospital

Introduction

Professor Dilip Nathwani OBE, Director, Academic Health Sciences Partnership [AHSP] in Tayside and Honorary Professor of Infection, Ninewells Hospital and Medical School, Dundee

Introduction to the challenges of treating multi-drug resistant gram-negative infections

Professor Peter Hawkey, Institute of Microbiology and Infection (IMI), University of Birmingham

Interactive Debate

Panel discussion

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries

Dr Jon Otter, Honorary Senior Lecturer, Imperial College London

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries

Dr Jon Otter, Honorary Senior Lecturer, Imperial College London